Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Use this CTXR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CTXR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CTXR SEC filings page. Lician reads the product cache first so this HTML stays unique to Citius Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full CTXR income, balance, and cash tables.